Paclitaxel
DrugBank ID: DB01229
Summary
| Metric | Value |
|---|---|
| Total Predictions | 71 |
| KG+DL (Dual Validated) | 9 |
| DL Only | 41 |
| KG Only | 21 |
Predictions
| Indication | Score | Source |
|---|---|---|
| female breast carcinoma | 1.0000 | DL |
| hereditary breast ovarian cancer syndrome | 0.9995 | DL |
| estrogen-receptor negative breast cancer | 0.9991 | DL |
| Ehrlich tumor carcinoma | 0.9991 | DL |
| estrogen-receptor positive breast cancer | 0.9991 | DL |
| hormone-resistant breast carcinoma | 0.9991 | DL |
| bilateral breast carcinoma | 0.9989 | DL |
| breast carcinoma by gene expression profile | 0.9989 | DL |
| nipple carcinoma | 0.9989 | DL |
| ovarian clear cell adenocarcinoma | 0.9988 | KG+DL |
| parameningeal embryonal rhabdomyosarcoma | 0.9973 | DL |
| botryoid-type embryonal rhabdomyosarcoma of the vagina | 0.9973 | DL |
| borderline epithelial tumor of ovary | 0.9972 | KG+DL |
| rhabdomyosarcoma (disease) | 0.9972 | DL |
| embryonal extrahepatic bile duct rhabdomyosarcoma | 0.9971 | DL |
| prostate embryonal rhabdomyosarcoma | 0.9969 | DL |
| maligant granulosa cell tumor of ovary | 0.9966 | KG+DL |
| Ewing sarcoma | 0.9966 | DL |
| extrahepatic bile duct rhabdomyosarcoma | 0.9966 | DL |
| ovarian endometrioid adenocarcinoma | 0.9965 | KG+DL |
| liver sarcoma | 0.9964 | DL |
| endometrial mixed adenocarcinoma | 0.9963 | DL |
| villoglandular endometrial endometrioid adenocarcinoma | 0.9963 | DL |
| ovarian mucinous adenocarcinoma | 0.9961 | KG+DL |
| mucin-rich endometrial endometrioid adenocarcinoma | 0.9958 | DL |
| secretory uterine corpus endometrioid adenocarcinoma | 0.9958 | DL |
| endometrial mucinous adenocarcinoma | 0.9958 | DL |
| stage I endometrioid carcinoma | 0.9955 | DL |
| stage II endometrioid carcinoma | 0.9955 | DL |
| rectum mucinous adenocarcinoma | 0.9954 | DL |
| cervical endometrioid adenocarcinoma | 0.9954 | DL |
| colon mucinous adenocarcinoma | 0.9953 | DL |
| rete ovarii adenocarcinoma | 0.9953 | DL |
| Krukenberg carcinoma | 0.9950 | DL |
| cervical mucinous adenocarcinoma | 0.9949 | DL |
| ovarian small cell carcinoma | 0.9948 | KG+DL |
| malignant non-dysgerminomatous germ cell tumor of ovary | 0.9948 | KG+DL |
| gallbladder mucinous adenocarcinoma | 0.9948 | DL |
| primary non-gestational choriocarcinoma of ovary | 0.9947 | KG+DL |
| yolk sac tumor | 0.9946 | KG+DL |
| extrahepatic bile duct mucinous adenocarcinoma | 0.9943 | DL |
| lung colloid adenocarcinoma | 0.9943 | DL |
| uterine corpus sarcoma | 0.9942 | DL |
| ovarian cystadenocarcinoma | 0.9941 | DL |
| endometrial clear cell adenocarcinoma | 0.9937 | DL |
| neuroblastoma | 0.9935 | DL |
| adult germ cell tumor | 0.9933 | DL |
| familial ovarian cancer | 0.9932 | DL |
| orbit sarcoma | 0.9927 | DL |
| synovial chondromatosis | 0.9927 | DL |
Showing top 50 of 71 predictions.
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.